The global in-vitro diagnostics (IVD) markets were estimated to be $30.6 billion in 2005. There currently exists great market potential for IVDs, especially considering that they only account for a small percentage of total healthcare costs. In particular, the development of molecular diagnostic assays that test for newly identified disease targets is fueling excitement over the promise of personalized medicine and theranostics. Additionally, demand for nearer to patient testing is driving major growth in point of care (POC) systems. Nevertheless, successfully igniting growth will depend on the effective promotion of the unquestionable role IVDs play in achieving greater patient success rates and optimizing patient management. Traditionally, healthcare providers have neglected to recognize the overall cost benefits that diagnostics offer, but new developments have called attention to their ability to provide early diagnosis, improve decision-making, and monitor treatment.
Frost & Sullivan is uniquely positioned to identify and analyze these complex trends in the Healthcare Information Systems industry, and help clients anticipate changes that will shape future market trends thereby arming them with the strategic tools required to minimize threats and maximize opportunities.
What We Offer in this Subscription
Our Clinical Diagnostics market engineering research team covers the market from a regional and global perspective to provide Growth Partnership Services clients with information, including:
- Market trends, market size and forecasted growth
- Competitive analysis, including market share of major participants
- Drivers and restraints of the market
- Emerging challenges, strategic recommendations, and growth strategies
- Regulatory and reimbursement factors
Incorporating a global perspective with proven methodologies and experienced analysts, Frost & Sullivan supports its clients in effectively managing risk and achieving profitability and growth objectives. Partnering with Frost & Sullivan allows clients to successfully identify and address current trends and challenges, develop fresh ideas to gain a competitive advantage, and meet aggressive growth objectives.
This subscription covers the global Clinical Diagnostics marketplace, including research on the North American, Latin American, European and Asia Pacific markets.